medicament 3004909234
CN → US| HS编码 | 关税税率 | 原产国 | 目的国 | 文档 |
|---|---|---|---|---|
| 3004490030 | 10.0% | CN | US | 官方文档 |
| 3004490040 | 10.0% | CN | US | 官方文档 |
| 3003490000 | 10.0% | CN | US | 官方文档 |
| 3003900190 | 10.0% | CN | US | 官方文档 |
| 3004490050 | 10.0% | CN | US | 官方文档 |
| 3004490070 | 10.0% | CN | US | 官方文档 |
商品图片
AI分析
💊 Medicament (Pharmaceutical Products)
🌐 HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional Clearance Strategy
📌 I. Product Definition & Classification: Do You Really Understand "Medicament"?
Medicament, in international trade, refers to finished pharmaceutical products intended for the treatment, prevention, or diagnosis of diseases in humans or animals. Unlike raw active ingredients (which may fall under Chapter 29), medicaments are formulated mixtures containing active substances, excipients, and sometimes flavorings or preservatives, ready for administration.
⚠️ Key Distinction:
- Raw Active Ingredients → Typically Chapter 29 (e.g., 2933, 2941, etc.)
- Formulated Medicaments → Chapter 30 (specifically heading 30.04 or 30.03)
- Key Factor: Is it a "preparation" for therapeutic/preventive use? If yes → HS Code 3004/3003.
📦 II. HS Code Classification Details (2026 Latest Tariff Authoritative Mapping)
Based on the provided data, the following HS Codes are identified for "Medicament." All listed codes carry a 10% Total Tariff Rate due to specific US trade policies.
| HS Code | Product Description | Reason for Classification | Total Tax Rate |
|---|---|---|---|
3004.49.00.30 |
Medicament; other medicaments containing antibiotics or hormones | No material or form conflict; directly matches therapeutic use definition. | 10.0% |
3004.49.00.40 |
Medicament; other medicaments | Directly corresponds to drug use definition; no material or form conflict. | 10.0% |
3003.49.00.00 |
Medicaments (not in dosage form); containing alkaloids or other natural derivatives | Named as "Medicament"; aligns with drug use definition; leans towards category with alkaloids or other ingredients. | 10.0% |
3003.90.01.90 |
Medicaments (not in dosage form); other | Named as "Medicament"; meets therapeutic/preventive purpose; classified under residual "other" category based on fallback rules. | 10.0% |
3004.49.00.50 |
Medicament; other medicaments | Name points to drug; purpose (treatment/prevention) fully aligns with code definition. | 10.0% |
3004.49.00.70 |
Medicament; other medicaments | Named as drug; meets therapeutic/preventive use definition; no material or form conflict. | 10.0% |
🔍 Critical Note:
- All suggested HS Codes are within Chapter 30 (Pharmaceutical Products).
- The distinction between 30.03 (not in dosage form) and 30.04 (in dosage form or packaged for retail) depends on the physical state. However, the provided data groups them similarly in tax outcome due to the 10% IEEPA surtax.
- User Input "3004909234": This appears to be a truncated or slightly varied version of the 10-digit HS codes above (e.g.,3004.90.92.34is not in the provided data, but3004.49.00.30is). We strictly adhere to the provided<DATA>list.
💰 III. 2026 Latest Tariff Rate Detailed Explanation (Including Surtaxes)
✅ Applicable Country: United States (US)
✅ Origin: China (CN) (Implied by "122 Section" and IEEPA context in data)
✅ Effective Date: Current (2025-2026)
🎯 1. Understanding the "10% Total Tax" for Medicaments
All listed HS Codes (3004.49.00.30, 3004.49.00.40, 3003.49.00.00, 3003.90.01.90, 3004.49.00.50, 3004.49.00.70) share the same tax structure:
| Item | Content |
|---|---|
| Base Tariff | 0.0% (Most medicaments have a 0% base MFN rate) |
| Retaliatory Tariff | 0.0% |
| "Section 122" Surtax | +10% |
| Total Tax Rate | 10.0% |
| Tax Calculation | CIF Value × 10% |
| De Minimis Exemption | ❌ Not Applicable (Pharmaceuticals are generally exempt from de minimis benefits for tariff purposes in high-surtax contexts) |
📌 Detailed Explanation of "122 Section Surtax 10%":
- This refers to the International Emergency Economic Powers Act (IEEPA) or related Executive Orders imposing additional tariffs on specific Chinese goods.
- Section 122 of the Trade Act of 1974 (or related administrative actions) is cited in the data source.
- Why 10%? This is a specific surtax applied to these pharmaceutical categories, likely as part of broader trade policy measures.
- No Base Tax? Because the base MFN rate is 0%, the entire 10% liability comes from this surtax.
🛠️ IV. Customs Clearance Practical Advice (Real-World Pitfall Avoidance)
✅ 1. Preparation Checklist (All Required)
| Document | Required | Description |
|---|---|---|
| ✅ Commercial Invoice | ✔️ | Must explicitly state "Medicament" or specific generic name (e.g., "Ibuprofen Tablets"). Avoid vague terms like "Supplements." |
| ✅ Certificate of Origin (CO) | ✔️ | To confirm origin and apply any potential FTAs (though US tariffs apply here). |
| ✅ Drug Listing Number (NDC) | ✔️ | For US imports, FDA requires National Drug Codes for most human drugs. |
| ✅ FDA Prior Notice | ✔️ | Must be filed with FDA before arrival. |
| ✅ Formula/Ingredients List | ✔️ | To justify HS Code classification (Active vs. Inactive ingredients). |
| ✅ Labeling Compliance | ✔️ | Must comply with US FDA labeling requirements (English language, warnings, dosage). |
| ✅ Packing List | ✔️ | Detail quantity, weight, and package dimensions. |
✅ 2. Declaration Tips (Key Mnemonics)
🔥 "Specify Generic Name, Avoid Vague Terms, FDA Clearance is Key!"
| Scenario | Correct Declaration | Wrong Practice |
|---|---|---|
| Finished Tablets/Capsules | 3004.49.00.xx + Specific Generic Name (e.g., "Amoxicillin Capsules") |
"Vitamins" or "Herbal Supplements" (Misclassification Risk) |
| Powder for Reconstitution | 3004.49.00.xx or 3003.xx |
"Raw Chemical" (If already formulated for medical use) |
| Over-the-Counter (OTC) | 3004.49.00.xx |
Omitting FDA NDC number |
| Prescription Drugs | 3004.49.00.xx |
Failure to provide FDA Prior Notice |
✅ 3. Special Circumstances Handling
| Scenario | Handling Advice |
|---|---|
| Biologics | May fall under 3002 or 3004 depending on formulation; ensure FDA approval. |
| Homeopathic Remedies | Risky; often scrutinized. Ensure they meet FDA definition of "Drug" vs. "Supplement." |
| Veterinary Medicaments | Same HS codes apply, but require USDA/FDA CVM approval if for animal use. |
| Generic Drugs | Ensure ANDA (Abbreviated New Drug Application) approval is referenced if required. |
🌍 V. Global Market Comparison (2026 Latest)
| Country/Region | Recommended HS Code | Tariff Rate | Certification | Notes |
|---|---|---|---|---|
| 🇺🇸 USA | 3004.49.00.xx / 3003.xx |
10% (Surtax only) | FDA NDC, Prior Notice | 10% IEEPA surtax applies to China-origin drugs. |
| 🇨🇳 China | 3004.49.00.xx |
5% | GMP, Registration | No IEEPA surtax. |
| 🇪🇺 EU | 3004.49.00.xx |
0% - 4% | EMA, CE | Varies by active ingredient. |
| 🇯🇵 Japan | 3004.49.00.xx |
0% - 5% | PMDA Approval | Strict labeling laws. |
| 🇬🇧 UK | 3004.49.00.xx |
0% - 5% | MHRA Approval | Post-Brexit rules apply. |
📌 Conclusion:
- US Market: The 10% surtax is the primary cost driver.
- Compliance: FDA regulations are the biggest hurdle, not just tariffs.
📌 VI. Common Mistakes & Pitfall Guide (Lessons Learned)
❌ Mistake 1: Declaring "Medicament" without a generic name.
👉 Consequence: Customs may reject the declaration, delay shipment, or misclassify, leading to penalties + storage fees.
❌ Mistake 2: Misclassifying "Supplements" as "Medicaments."
👉 Consequence: If it contains drugs, it’s a medicament (10% tax + FDA); if it’s a supplement, it might be exempt from some drug regulations but not tariffs. Misclassification = Audit Risk.
❌ Mistake 3: Ignoring FDA Prior Notice.
👉 Consequence: Refusal of Entry by FDA. The cargo will be held or destroyed.
❌ Mistake 4: Assuming 0% Base Tariff means 0% Total Tax.
👉 Consequence: 10% Surtax still applies. Total liability is 10%, not 0%.
✅ Correct Approach:
"Amoxicillin Capsules, 500mg, for Retail Sale, NDC: 12345-678-90, FDA Approved, Origin: China"
🎯 VII. Conclusion: Precision in Classification Saves Costs!
🎯 Remember Mnemonic:
🔹 "Generic Name is Key, FDA Notice is Mandatory, 10% Surtax is Real, Don’t Guess the HS!"
🔹 "Base 0% + Surtax 10% = Total 10%, Clear Correctly to Stay Safe!"
📌 Pro Tip:
- If your medicament is originating from Vietnam, Mexico, or Thailand, it MAY be eligible for IEEPA exemptions (lower or 0% tariff), but FDA compliance remains mandatory.
- Always apply for an Advance Ruling from US Customs (CBP) if the classification is ambiguous, especially for complex formulations.
📣 Immediate Action:
📞 Contact a Licensed Customs Broker + Provide FDA NDC + Invoice with Generic Name
🚀 Ensure Smooth Clearance, Avoid Delays, and Manage Tariff Costs Efficiently!
✨ Professional Clearance Starts with Accurate Classification!
💼 Every Dollar in Tariffs Counts – Know Your 10%!
用户评价
关于 HS 编码归类
协调制度(HS)是由世界海关组织(WCO)制定的国际贸易商品分类标准。全球 200 多个国家采用 HS 系统作为海关关税、贸易统计和进出口监管的基础。
每个 HS 编码遵循以下层级结构:
- 章(2 位)——商品大类(例如:第 84 章:机器和机械设备)
- 品目(4 位)——章内的更具体分类
- 子目(6 位)——国际通用细分,所有 WCO 成员国统一使用
- 本国细分(8-10 位)——各国自行扩展的细分编码,如美国 HTSUS 10 位编码
正确的 HS 编码归类对于顺利通关、准确缴纳关税和遵守贸易法规至关重要。错误归类可能导致海关延误、多缴关税或罚款。
从CN进口到US时,适用的关税税率可能包括:
- 最惠国(MFN)税率——适用于 WTO 成员国的标准关税税率
- 普通税率——适用于无贸易协定国家
- 贸易救济关税——附加关税,如 301 条款(反倾销)、232 条款(国家安全)或反补贴税
本页内容仅供参考。如需正式归类,请咨询当地海关或持牌报关代理。